Distinct Clinic-Pathological Features of Early Differentiated-Type Gastric Cancers after Helicobacter pylori Eradication

Abstract EN

Background.

Gastric cancer is discovered even after successful eradication of H.

pylori.

We investigated clinic pathological features of early gastric cancers after H.

pylori eradication.

Methods.

51 early gastric cancers (EGCs) from 44 patients diagnosed after successful H.

pylori eradication were included as eradication group.

The clinic-pathological features were compared with that of 131 EGCs from 120 patients who did not have a history of H.

pylori eradication (control group).

Results.

Compared with control group, clinic-pathological features of eradication group were characterized as depressed ( p < 0.0001 ), reddish ( p = 0.0001 ), and smaller ( p = 0.0095 ) lesions, which was also confirmed in the comparison of six metachronous lesions diagnosed after initial ESD and subsequent successful H.

pylori eradication.

Prevalence of both SM2 (submucosal invasion greater than 500 μm) and unexpected SM2 cases tended to be higher in eradication group ( p = 0.077 , 0.0867, resp.).

Prevalence of inconclusive diagnosis of gastric cancer during pretreatment biopsy was also higher in the same group (26.0% versus 1.6%, p < 0.0001 ).

Conclusions.

Informative clinic pathological features of EGC after H.

pylori eradication are depressed, reddish appearances, which should be treated as a caution because histological diagnosis of cancerous tissue is sometimes difficult by endoscopic biopsy.